Tarsus Pharmaceuticals, Inc. (TARS)
63.81
+2.26
(+3.67%)
USD |
NASDAQ |
Jun 10, 10:00
Tarsus Pharmaceuticals EPS Diluted (Quarterly) : -0.1622 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Structure Therapeutics, Inc. | -1.052 |
| Eton Pharmaceuticals, Inc. | 0.0493 |
| Alumis, Inc. | -0.7441 |
| Veradermics, Inc. | -0.8037 |
| ANI Pharmaceuticals, Inc. | 1.276 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -6.967M |
| Revenue (Quarterly) | 162.05M |
| Total Expenses (Quarterly) | 169.02M |
| Enterprise Value | 2.348B |
| Gross Profit Margin (Quarterly) | 94.20% |
| Profit Margin (Quarterly) | -4.30% |
| Earnings Yield | -1.78% |
| Normalized Earnings Yield | -1.776 |